People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Emergo Therapeutics, Inc. | — | Pharmaceuticals | Series A | $16.0M | $6.9M | 2018 |
John E. Bailey, Jr. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John E. Bailey, Jr. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| MOISE KHAYRALLAH | 1 | 5 |
| Robert Helmedag | 1 | 3 |
| Margaret Powell | 1 | 3 |
| Margaret E. Powell | 1 | 1 |
| Robert E. Helmedag | 1 | 1 |
| Robin Hyde-DeRuyscher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.